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Demonstration of PDGF B-chain mRNA in glomeruli in mesangial
proliferative nephritis by in situ hybridization. We used the technique of
in situ hybridization to determine if cells expressing PDGF B-chain
mRNA can be detected in a model of mesangial proliferative nephritis
in the rat induced with antibody directed against the Thy 1 antigen
present on the mesangial cell membrane. The method involved hybrid-
ization with a digoxigenin-labeled cRNA probe for the murine PDGF
B-chain followed by detection with an anti-digoxigenin-alkaline phos-
phatase conjugate and subsequent colorimetric reaction. In normal rats(N = 4), the majority of glomeruli (74%) were negative for PDGF
B-chain mRNA, whereas 65% of glomeruli from rats with mesangial
proliferative nephritis (N = 4) had segmental or diffuse staining for
PDGF B-chain mRNA in a mesangial pattern. The difference, as
measured using a semiquantitative scale, was significant (mean scores
0,4 0.2 vs. 1.9 0.2; scale 0 to 3+; P <0.001). The increase in PDGF
B-chain mRNA positive cells localized to areas of hypercellularity and
was associated with a significant increase in cells positive for PDGF
B-chain by immunostaining with a specific monoclonal antibody (0.8
0.1 vs. 1.7 0.4, scale 0 to 3+, normal vs. diseased rats, P < 0.005).
Complement depletion, which prevents the mesangial cell proliferation,
also prevented the increase in cells expressing PDGF B-chain mRNA
and protein. Thus, this method of in situ hybridization can successfully
detect cells expressing PDGF mRNA in active glomerulonephritis, and
may be useful for detecting cells expressing genes for other growth
factors and cytokines in both human and experimental models of
glomerular injury.
Mesangial cells in culture will proliferate in response to
numerous growth factors, including platelet-derived growth
factor (PDGF), interleukin 1 (IL-i), and interleukin 6 (IL-6)
[1—31. Recently the involvement of PDGF [4, 5], IL-i [6—8], IL-6
[3], growth hormone [9], and transforming growth factor beta
(TGF-3) [10, ii] in experimental or human mesangial prolifer-
ative glomerular disease has been demonstrated. Although
mRNAs for these growth factors have been demonstrated in
Northern blots of whole kidney [4, 6—8] or glomerular [5, 10]
RNA from animals with glomerular disease, the identification of
growth factor mRNA in glomerulonephritis by in situ hybrid-
ization has not been previously reported.
In this paper, we describe a non-radioactive method for
performing in situ hybridization which offers precise localiza-
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tion of mRNA in fixed tissue sections. Utilizing this method, we
examined a rat model of mesangial proliferative nephritis and
demonstrate a marked increase in cells expressing PDGF
B-chain mRNA in mesangial locations as compared to normal
rats. The increase in cellular expression of PDGF B-chain
mRNA corresponds with an increase in cells that express
PDGF B protein, and coincides with mesangial cell prolifera-
tion. These changes in PDGF expression can be prevented by
complement depletion, a maneuver that also prevents the
cellular proliferation. Thus, this study provides the first dem-
onstration of the use of in situ hybridization to explore the
growth factors involved in proliferative glomerulonephritis.
Methods
Experimental protocol
The experiments were designed to determine if cells express-
ing PDGF mRNA could be identified in glomeruli in a model of
mesangial proliferative nephritis in the rat induced with anti-
Thy 1 antibody. This model is associated with a complement
dependent mesangiolysis that peaks at day 1, followed by
mesangial cell proliferation occurring three to five days after
disease induction [12, 13]. This model was chosen because we
have demonstrated previously by Northern analysis that gb-
merular RNA for the PDGF B-chain increases 8 to 10-fold with
the onset of proliferation [5].
Three groups of Wistar rats (Simonsen, Gilroy, California,
USA) were studied: a) normal unmanipulated rats (N = 4); b)
rats with anti-Thy I GN at 3 days after disease induction (N =
4); and c) Rats with anti-Thy I GN (day 3) that were comple-
ment depleted with cobra venom factor (CVF) (N = 4).
For each group of rats, kidney tissue was obtained at sacri-
fice. The glomerular localization of PDGF B-chain mRNA was
determined by in situ hybridization using a specific cRNA probe
for the murine PDGF B-chain. Tissue was also stained by
immunoperoxidase for proliferating cells (utilizing an antibody
to the proliferating cell nuclear antigen (PCNA) [14]) and for
PDGF B-chain protein (with a specific monoclonal antibody
115]).
Disease model and complement depletion. The disease was
induced by a single intravenous injection of goat anti-rat thy-
mocyte plasma (ATS) (0.4 ml/l00 g body wt) as previously
reported [12—14]. Complement depletion was achieved in four
rats by the intraperitoneal injection of CVF (Naja naja
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kaounthia, Diamedix Corp., Miami, Florida, USA) (30 U i.p.) in
three divided doses beginning 24 hours prior to injection of ATS
with repeated daily injections (10 U i.p.) until sacrifice. Serum
C3 levels in the CVF-treated rats obtained at the time of
injection of ATS and at sacrifice three days later were <10% of
baseline (that is, pre-CVF injection) values as measured by
radial immunodiffusion.
In situ hybridization
Probe preparation. Murine PDGF B-chain genomic DNA (a
326 bp fragment containing 135 bp of Exon 6; gift of Dr. Charles
Stiles) was cloned into the Smal site of the transcription vector
pGEM1 at a site between the SP6 and T7 promoters [16]. The
template was linearized with the restriction enzyme BamH I
(anti-sense probe) or EcoRI (sense probe) and labeled RNA
probes were synthesized with T7 RNA polymerase (anti-sense
probe) or SP6 RNA polymerase (sense probe) using digoxige-
nm-labeled uridine-triphosphate (DIG-UTP) as substrate ac-
cording to the manufacturer's instructions (Genius RNA label-
ing kit, Boehringer-Mannheim, Mannheim, Germany) [17, 181.
Tissue preparation. Renal biopsy tissue was cut into pieces
(10 x 6 x 3 mm in size) with sterilized razor blades and fixed in
buffered 10% formalin for 24 hours and embedded in paraffin.
Using a standard rotary microtome, 4 m sections were cut and
floated in diethyl pyrocarbonate (DEPC, Sigma, St. Louis,
Missouri, USA) treated (0.1%) water, and placed on Vectabond
(Vector Laboratories, Burlingame, California, USA) coated
slides. Tissue sections were preheated at 42°C overnight, and
deparaffinated with Histoclear (National Diagnostics, Manville,
New Jersey, USA). Further tissue preparation was performed
according to the manufacturer's instructions for formalin-fixed
tissue (Technical Bulletin: In situ hybridizations, Boehringer-
Mannheim) [19, 20].
In situ hybridization. Sections were prehybridized in a humid
chamber for one hour at room temperature in hybridization
buffer, consisting of 50% deionized formamide (Bethesda Re-
search Laboratories, Bethesda, Maryland, USA), 4 x SSC (lx
SSC = 0.15 M NaCI and 0.015 M Na citrate), I x Denhardt's
solution (0.02% polyvinylpyrrolidone, 0.02% Ficoll type 400
and 0.02% BSA), 500 j.tg/ml heat-denatured herring sperm DNA
(Sigma), 250 jg/ml yeast tRNA (Sigma), and 10% dextran
sulfate (Sigma). Tissues were rinsed in 2 x SSC and incubated
with coverslips overnight at 55°C in 100 l of the hybridization
buffer containing 300 ng/ml labeled cRNA probe. After hybrid-
ization, sections were washed in 2 x SSC for one hour at room
temperature, then twice in 1 x SSC at room temperature for 30
minutes each and in 0.5 x SSC for 30 minutes at 55°C and 30
minutes at room temperature.
Colorimetric detection of mRNA following hybridization.
Detection was accomplished with the Genius Nonradioactive
Nucleic Acid Detection Kit (Boehringer-Mannheim) with mod-
ification. Slides were washed for one minute in Buffer 1(100 mrvi
Tris-HCI, 150 mM NaCI; pH 7.5) and then incubated in Buffer 1
containing 2% normal sheep serum and 0.3% Triton X-l00 at
room temperature for 30 minutes, and 100 M1 of anti-digoxigenin
antibody conjugated to alkaline phosphatase (1:500 dilution)
was applied onto the slides and incubated in a humid chamber
overnight at 4°C. Following washing in Buffer I and in Buffer 2
(100mM Tris-HCI, 100mM NaCI, 50mM MgCI2; pH 9.5), 100 l
of color solution was applied onto the slides and incubation was
carried out at room temperature in a dark, humid chamber. The
color solution was made by adding 45 d NBT [nitroblue
tetrazolium salt, 75 mg/mI in dimethylformamide, 70% (vol/vol),
35 l X-phosphate solution (5-bromo-4-chloro-3-indolyl phos-
phate, toluidium salt, 50 mg/mI, in dimethylformamide) and 2.4
mg levamisole (Sigma) to 10 ml Buffer 2. After 9 to 10 hours, the
color reaction was stopped with Buffer 3 (10 mrvt Tris-HCI, 1
mM EDTA; pH 8.0). After dehydration in a series of graded
ethanols, slides were placed in Histoclear for three minutes and
the tissue was coverslipped using a mixture of 66% Histomount
(National Diagnostics) and 34% Histoclear.
Controls. Anti-sense probe specificity was confirmed by
hybridization of a sense probe to matched serial sections, and
by hybridization of the anti-sense probe to tissue sections from
rats with anti-Thy 1 GN which had been incubated with 20
g/ml RNAase A (Sigma) before hybridization. Controls for the
specificity of the color detection system included hybridization
and color detection with deletion of probe or antibody or color
solution.
Quantiration of PDGF B chain mRNA by in situ hybridiza-
tion. The expression of PDGF B-chain mRNA in individual
glomeruli by in situ hybridization was quantitated based on the
distribution of positive cells within the glomerulus as follows:
grade 0: no positive cells in the glomerulus
grade 1: 1 or 2 positive cells in the glomerulus
grade 2: 3 or more positive cells in a segmental distribution
within the glomerulus
grade 3: many (4) positive cells of moderate to strong
intensity in a diffuse distribution (affecting more
than 2 segments) in the glomerulus
For each biopsy, all glomeruli in four sections were examined
and the percentage of glomeruli within each grade and a mean
grade value were calculated. This involved examining 321
different glomeruli in the group of normal rats, 389 glomeruli in
rats with anti-Thy I nephritis, and 263 glomeruli in the comple-
ment depleted rats with anti-Thy 1 nephritis. The mean grade
values for each individual biopsy were then used to calculate
the overall mean grade values for each group of animals.
Immunohistochemical staining
Biopsy tissue from each rat was fixed in methyl Carnoy's
solution (60% methanol, 30% chloroform, 10% acetic acid) and
4 m sections stained by the indirect immunoperoxidase
method for PCNA as previously described [14]. PCNA is an
auxiliary protein to DNA polymerase delta that is expressed in
late G1, peaking during the S phase, and extending to the M
phase of the cell cycle [21, 22]. Identification of cells expressing
this nuclear protein was performed using 19A2, an 1gM murine
monoclonal antibody to PCNA (American Biotech Inc., Plan-
tation, Florida, USA) [231.
Tissue was also stained for PDGF B-chain protein by indirect
immunoperoxidase using the murine monoclonal antibody
PGF-007 (Mochida Pharmaceutical, Tokyo, Japan) which was
generated to a 25 amino acid peptide located near the COOH-
terminus of the human PDGF B-chain [24]. The specificity of
the antibody has been characterized in fixed tissue sections by
studies of cell types known to express, or not to express, PDGF
B-chain, and by the ability to block the immunostaining by
incubation of the antibody with synthetic PDGF-BB but not
PDGF-AA [5, 15]. For all biopsy specimens, a negative control
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Table 1. Distribution of PDGF B-chain mRNA in glomeruli of
normal rats and in unmanipulated and complement depleted (CVF
treated) rats with mesangial proliferative nephritis (Anti-Thy I ON)
PDGF B-chain mRNA expression
0 1 2 3
Normal rats 74 II 17 4 5 3 4 4
Anti-Thy 1 ON, 14 6 21 4 25 2 40 9
day 3
Anti-Thy I GN-CVF, 69 8 21 6 4 I 6 3
day 3
Each value represents the percentage of glomeruli with this semi-
quantitative grade (see Methods for description of grades).
was performed in which the primary antibody (for example,
19A2 or PGF-007) was replaced with an irrelevant murine
monoclonal antibody.
Quantitation of PDGF B-chain protein. PDGF B protein was
quantitated by immunostaining in individual glomeruli using the
following semiquantitative scale:
grade 0—all glomerular cells and mesangial matrix negative
grade 1—weak staining of 1 or 2 cells and/or <25% of the
mesangium weakly positive
grade 2—intense staining of 1 or 2 cells, and/or weak
staining of 3 or more cells and 25—50% of the
mesangium positive
grade 3—intense cytoplasmic staining of 3 or more cells
and/or >50% of the mesangium positive.
For each biopsy, all glomeruli were scored and the percentage
of glomeruli in each grade calculated. A minimum of 20 glomer-
uli were scored in each biopsy. The overall score was calculated
as the mean of all biopsies in each group.
Statistical analysis
All values are expressed as the mean SEM. Comparisons
between groups were made using modified t statistics with the
Bonferroni correction.
Results
Detection of PDGF B-chain mRNA in glomeruli by in situ
hybridization
In situ hybridization was performed on paraffin embedded
sections of normal rat kidneys and kidneys from rats with
mesangial proliferative nephritis utilizing a digoxigenin-labeled
cRNA probe for the murine PDGF B-chain. In normal rat
kidney, 74% of glomeruli had no detectable PDGF B-chain
mRNA (grade 0) (Table 1, Fig. 1A). Occasional glomeruli had
one or two positive cells in mesangial regions (grade 1), and rare
glomeruli had scattered positive cells of weak intensity in
segmental (grade 2) or diffuse (grade 3) patterns (Table 1). Distal
tubules and collecting ducts, and to a lesser extent, proximal
tubules, were variably positive.
In contrast, rats with mesangial proliferative nephritis in-
duced with anti-Thy 1 antibody had a marked increase in
glomerular PDGF B-chain expression. Although some glomer-
uli had only one or two positive cells expressing PDGF B-chain
mRNA (Fig. lB), most glomeruli (65%) showed intense seg-
mental (grade 2, Fig. 1C) or diffuse (grade 3, Fig. ID) staining
(Table 1). In general, the glomeruli showing segmental or
diffuse staining for PDGF B-chain mRNA had corresponding
segmental or diffuse hypercellularity. Using a scale based on
the distribution of the PDGF B-chain mRNA within the glomer-
ulus, the mean value for glomerular PDGF B-chain mRNA in
the rats with mesangial proliferative nephritis was 1.9 0.2,
and was significantly greater than that observed in normal rats
(0.4 0.2, P < 0.001, Table 2). The increase in PDGF B-chain
mRNA expression was associated with an increase in glomer-
ular cell proliferation, as marked by immunostaining for the
nuclear protein, PCNA (Table 2).
In contradistinction to the major differences in expression of
PDGF B-chain mRNA observed in normal and diseased gb-
meruli, differences in tubular staining for PDGF B-chain mRNA
were more subtle (Fig. 2). There did appear to be a slight
increase in tubular cells expressing both PCNA antigen and
PDGF B-chain mRNA in diseased kidneys, but there was great
variability and differences were not quantifiable.
Rats with mesangial proliferative nephritis that were comple-
ment depleted with CVF had similar levels of PDGF B-chain
mRNA in glomeruli as compared to normal rats (0.5 0.1 vs.
0.4 0.2, P = NS, Table 2). As with normal rats, the great
majority of glomeruli (69%) were negative for the PDGF
B-chain transcript (Table 1, Fig. IE). This was consistent with
the lack of glomerular cell proliferation observed (Table 2).
Specificity of the anti-sense probe was demonstrated by lack
of staining of tissues treated with RNAase before prehybridiza-
tion, and lack of staining with the sense probe for PDGF
B-chain mRNA (Fig. lF). All controls for the color detection
system proved to be negative, confirming antibody and color
reagent specificity.
Demonstration of PDGF B-chain protein in glomeruli in
normal rats and in rats wit/i mesangial proliferative nephritis
Tissue was also immunostained for the PDGF B-chain pro-
tein using the monoclonal antibody, PGF-007, which is directed
against a peptide present in the human PDGF B-chain [24].
Normal gbomeruli had only rare and weakly positive cells for
PDGF B protein (Fig. 3A, Table 3). In contrast, in mesangial
proliferative nephritis there was a marked increase in the
number and intensity of cells positive for the PDGF B protein in
mesangial locations (Fig. 3B, Table 3). The increase in PDGF B
protein in glomeruli was abolished by complement depletion
(Fig. 3C, Table 3). Thus, the pattern for PDGF B protein
staining paralleled the changes in PDGF B-chain mRNA
expression.
Tubular cells were also variably positive for PDGF B protein
in normal and diseased rats. The specificity was confirmed by
substituting an irrelevent murine monoclonal antibody for the
anti-PDGF antibody, and by blocking experiments in which the
antibody staining could be abolished by incubation of the
anti-PDGF antibody with synthetic PDGF-BB but not PDGF-
AA. Although a greater number of tubules were positive at the
dilution of antibody used in this study, when lower concentra-
tions of anti-PDGF antibody were substituted, the tubular
staining more closely parallelled the staining pattern of PDGF
B-chain mRNA.
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Fig. 1. In situ hybridization for the PDGF B-chain inRNA in glomeruli of nor,nal and diseased rats. In normal rats, glomeruli were usually
negative (A) for PDGF B-chain mRNA. Although a small proportion of glomeruli from rats with mesangial proliferative nephritis had occasional
cells positive for PDGF B-chain mRNA (B), most glomeruli had segmental (C) or diffuse (D) staining in a mesangial distribution. Complement-
depleted rats with anti-Thy 1 GN had a pattern of staining similar to normal rats (E). Tubules were variably positive in all three groups.
Hybridization with the sense probe in both normal (F) and diseased rats resulted in no staining of the glomeruli or of the tubules. (400X)
Discussion
Recently there has been great interest in studying the gene
expression of various growth factors and cytokines in glomer-
ulonephritis. Most studies have utilized the technique of North-
ern blotting to demonstrate upregulation of IL-I [6—8], TGF-/3
[10, lij, or PDGF [4, 5] mRNA in RNA extracted from either
whole kidneys [4, 6—8] or isolated glomeruli [5, 10, II] in
experimental models of glomerulonephritis.
In this study, the technique of in situ hybridization was used
to localize PDGF B-chain mRNA in glomeruli in mesangial
proliferative nephritis in the rat induced with anti-Thy 1 anti-
body. Glomeruli from normal rats were usually negative for
PDGF B-chain mRNA. In contrast, numerous cells expressing
PDGF B-chain mRNA were present in both a segmental and
diffuse mesangial distribution in rats with glomerulonephritis.
The presence of PDGF B-chain mRNA positive cells localized
to areas of hypercellularity and coincided with an increase in
proliferating cells as documented by immunostaining for
PCNA, a cell proliferation marker [21, 22]. Complement deple-
tion, which has been previously reported to block the glomer-
ular cell proliferation in this model [12, 13], prevented the
increase in glomerular cells expressing PDGF B-chain mRNA.
Thus, the presence of PDGF B-chain mRNA positive cells
correlates with the mesangial cell proliferation. This study
0'I
p
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Table 2. Analysis of degree of proliferation (PCNA+) and level of
PDGF B-chain mRNA and protein present per glomerulus in normal
rats and unmanipulated and complement depleted (CVF treated) rats
with mesangial proliferative nephritis (anti-Thy 1 GN)
PCNA+b
PDGF Bchaina
mRNA Protein
Normal rats 1.4 0.1 0.4 0.2 0.8 0.1
Anti-Thy 1 GN, 12.8 0.5C 1.9 0.2C 1.7 02d
day 3
Anti-Thy I GN-CVF, 1.2 0.5 0.5 0.1 0.8 0.1
day 3
a Graded semiquantitatively from 0-3+ (Methods), bnumber of
PCNA+ cells per glomerular cross section, ' P < d P < 0.005
relative to normal rats
Fig. 2. Low power view (100 x) of renal cortex from a normal rat (A)
and a rat with mesangial proliferative nephritis (day 3) (B) following in
situ hybridization for PDGF B-chain mRNA. Staining of the tubules(predominantly distal tubules and collecting ducts) is present in the
normal rat, and appears to be slightly increased in the rat with
mesangial proliferative nephritis.
confirms our previous observation that PDGF B-chain mRNA
is increased in whole glomerular RNA in rats with this model of
nephritis as measured by Northern blotting [5].
The etiology of the cells expressing the PDGF B-chain
mRNA is uncertain. PDGF could originate from a variety of cell
types within the glomerulus, including the monocyte-macro-
phage, the glomerular endothelial cell, the platelet, the smooth
muscle-like mesangial cell, or the Ia+ mesangial cell [25, 26]. In
a previous study, we suggested that the majority of the PDGF is
actually being synthesized by a subpopulation of smooth mus-
Fig. 3. Immunostaining for the PDGF B protein in normal and
diseased glomeruli. Glomeruli from normal rats were usually negative
for the PDGF B protein (A), although tubules were positive. In
mesangial proliferative nephritis there was a significant increase in cells
positive for the PDGF B protein within the mesangial regions of the
glomerulus (B). Rats with anti-Thy 1 GN that had been complement
depleted with CVF had a staining pattern similar to normal rats (C).
(Immunoperoxidase, 400 x).
cle-like mesangial cells [5]. In that study, a small number of
PDGF B protein positive cells were identified in glomeruli of
diseased rats (averaging 2 positive cells/glomerular cross sec-
tion) using an indirect immuno-alkaline phosphatase method
[5]. By double immunolabeling, >85% of the glomerular cells
that were positive by immunostaining for PDGF B protein also
expressed a-smooth muscle actin [5]. a-Smooth muscle actin is
a smooth muscle-specific marker that is expressed by prolifer-
ating mesangial cells, and is not expressed by glomerular
endothelial cells or macrophages [27].
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Table 3. Distribution of PDGF B-chain protein in glomeruli in
normal rats, rats with mesangial proliferative nephritis (anti-Thy 1
ON) and complement depleted rats with mesangiat proliferative
nephritis (anti-Thy 1 ON-CVF)
PDGF B protein
0 I 2 3
Normal rats 20 5 78 5 3 2 0 0
Anti-Thy 1 ON, 4 2 39 10 35 3 22 10
day 3
Anti-Thy 1 ON-CVF, 21 5 77 5 2 1 0 0.2
day 3
Each value represents the percentage of glomeruli with this semi-
quantitative grade (see Methods for description of grades).
The current study further clarifies certain issues raised by the
original study. First, it confirmed that cells expressing PDGF
B-chain mRNA and protein were increased in mesangial prolif-
erative nephritis, and that they localized to the areas of mesan-
gial hypercellularity. Second, the observation in the original
paper that only a small number of PDGF B protein positive cells
were present in diseased glomeruli implied that only a small
population of cells were expressing PDGF. However, the
number of PDGF B-chain positive cells detected by in situ
hybridization (for mRNA) and by the immunoperoxidase
method (for PDGF B protein) was substantially greater, pre-
sumably due to better detection sensitivity, and is more com-
patible with the hypothesis that the proliferating mesangial cell
is expressing PDGF. Finally, by identifying cells expressing
PDGF B-chain mRNA in niesangial regions, this study allays
the concern that positive immunostaining of mesangial cells for
PDGF B protein may simply reflect binding of exogenous
PDGF to the mesangial cell PDGF receptor. Thus, these studies
would appear to support in vitro observations that PDGF can
act as an autocrine growth factor for mesangial cells [261, and
suggest that this process may be occurring in mesangial prolif-
erative nephritis.
An interesting finding in the study was that kidney tubules
express PDGF B-chain mRNA and stain for the PDGF B
protein. Previous investigators have reported that nontrans-
formed monkey kidney epithelial cells express both PDGF
B-chain mRNA and protein in culture [281. We noted variable
staining of tubules in the renal cortex (principally distal tubules
and collecting ducts) with greater and more consistent staining
of tubules in the medulla (data not shown). There did appear to
be a slight increase in tubular staining for PDGF B-chain mRNA
and PCNA in the renal cortex of rats with mesangial prolifera-
tive nephritis. This suggests that injury within the glomerulus
may result in the release of inflammatory mediators that could
affect the surrounding tubulo-interstitium.
One difficulty encountered with the method of in situ hybrid-
ization was the need to develop a sensitive way for quantitating
differences in glomerular mRNA expression. Our semiquanti-
tative scale was based primarily on the distribution of the PDGF
mRNA within the glomerulus, as opposed to the intensity of the
signal within individual cells. However, it was apparent that the
lesions associated with a segmental or diffuse pattern of PDGF
mRNA in glomeruli were almost invariably associated with a
more intense signal of PDGF mRNA on a per cell basis.
Despite the problems in quantitation, the technique of in situ
hybridization offers distinct advantages over previously re-
ported methods [4—8, 10, 11] to examine the gene expression of
various growth factors and cytokines in glomerulonephritis. By
providing precise localization of mRNA within the glomerulus,
in situ hybridization 1) abolishes concerns about the contribu-
tion of tubular or interstitial cell RNA in whole kidney or
glomerular RNA preparations; 2) provides information as to the
localization of the gene expression within glomeruli that may be
crucial in the interpretation of lesions that are focal in nature; 3)
provides the opportunity for double immunolabeling studies in
which the identity of the cells expressing the genes can be
established [291; and 4) allows the study of human kidney tissue
obtained by routine biopsy.
In situ hybridization was performed in our study utilizing a
digoxigenin-labeled cRNA probe for the murine PDGF B-chain
mRNA. Digoxigenin is a steroid hapten that is linked via a
spacer-arm to deoxyuridine-triphosphate [17]. Digoxigenin-1 1-
dUTP is an analogue of TTP, and is incorporated into RNA by
in vitro transcription using SP6 or T7 RNA polymerases. The
hybrids are detected with an anti-digoxigenin antibody conju-
gated to alkaline phosphatase which is then visualized using an
enzyme-catalyzed color reaction with 5-bromo-4-chloro-3-in-
dolyl phosphate and nitroblue tetrazolium salt [17]. Digoxige-
nm-labeled probes are equal to or more sensitive than radiola-
beled probes [17], and have distinct advantages over methods
using radioactive isotopes, including 1) a short (<72 hrs) color
reaction time; 2) no background signal due to the fact that
digoxigenin is not normally present in animal tissues; and 3) the
avoidance of the biological hazards and special laboratory
requirements involved with the use of radioactive materials [17,
19].
Although in situ hybridization has been used to study the
location of the mRNA for a variety of substances in the kidney
[30—33], there has been general concern that the low levels of
mRNA for growth factors and cytokines might make it very
difficult to identify these factors in glomeruli in normal or
diseased states. This study demonstrates the feasibility of in
situ hybridization utilizing digoxigenin-labeled probes to local-
ize cells expressing the growth factor, PDGF, in glomerulone-
phritis, and should provide an impetus to study the gene
expression of other cytokines and growth factors in both human
and experimental glomerular diseases.
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